Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

Cancer Immunology Immunotherapy

Volumn 43, Issue 4, 1996, Pages 245-253

  Heider, Karl Heinz ^a   Sproll, Marlies ^a   Susani, Susanne ^b   Patzelt, Erik ^a   Beaumier, Paul ^c   Ostermann, Elinborg ^a   Ahorn, Horst ^a   Adolf, Günther R ^a  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Poniard Pharmaceuticals Inc   (United States)

Author keywords

CD44 isoforms; monoclonal antibody; radioimmunotherapy; squamous cell carcinomas; tumor targeting

Indexed keywords

HERMES ANTIGEN; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IODINE RADIOISOTOPES; ISOMERISM; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS; RADIOIMMUNODETECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030454435     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050329     Document Type: Article

References (34)

1. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682
2. Brooks L, Niedobitek G, Agathanggelou A, Farrell P (1995) The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. Am J Pathol 146: 1102
3. Dall P, Heider KH, Hekele A, Minckwitz G von, Kaufmann M, Ponta H, Herrlich P (1994) Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 54: 3337
4. Dean C, Modjtahedi H, Eccles S, Box G, Styles J (1994) Immunotherapy with antibodies to the EGF receptor. Int J Cancer [Suppl] 8: 103
5. Finke LH, Terpe HJ, Zörh C, Haensch W, Schlag PM (1995) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 345: 583
6. Fox SB, Fawcett J, Jackson DG (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isofbrms. Cancer Res 54: 4539
7. Goldenberg DM, Larson SM, Reisfeld RA, Schlom J (1995) Targeting cancer with radiolabelled antibodies. Immunol Today 16: 261
8. Günthert U (1993) CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184: 47
9. Günthert U, Hofmann M, Rudy W, Reher S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13
10. Guttinger M, Sutti F, Barnier C, Mackay C, Berti H (1995) Expression of CD44 standard and variant forms in skin tumors. Loss of CD44 correlates with aggressive potential. Eur J Dermatol 5: 398
11. Hall SS (1995) Monoclonal antibodies at age 20: promise at last? Science 270: 915
12. Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H (1993) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197
13. Heider KH, Hofmann M, Horst E, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomalous polyps. J Cell Biol 120: 227
14. Heider KH, Mulder JWR, Ostermann E, Susani S, Patzelt E, Pals ST, Adolf GR (1995) Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumor cells are expressed in normal tissues of humans and cynomolgus monkeys. Eur J Cancer 31A: 2385
15. Herrlich P, Zöller M, Pals ST, Ponta H (1993) CD44 splice variants: metastases meet lymphocytes. Immunol Today 14: 395
16. Hofmann M, Rudy W, Zöller M. Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed human tumor cell lines. Cancer Res 51: 5292
17. Kaufmann M, Heider KH, Sinn HP, Minckwitz G von, Ponta H. Herrlich P (1995) CD44 variant exon epilopes in primary breast cancer and length of survival. Lancet 345: 615
18. Koopman G, Heider KH, Horst E, Adolf GR, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897
19. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271
20. Mackay CR, Terpe HJ, Stauder R, Marston W, Stark H, Günthert U (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71
21. Mulder JWR, Kruyt PhM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Expression of exon v6 containing CD44 proteins in human colorectal cancer is associated with unfavorable prognosis in long term follow up. Lancet 344: 1470
22. Quak JJ, Dongen G van, Balm AJM, Brakkee JPG, Scheper RJ, Snow GB, Meijer CJLM (1990) A 22-kDA surface antigen detected by monoclonal antibody E48 is exclusively expressed in stratified squamous and transitional epithelia. Am J Pathol 136: 191
23. Rudy W, Hofmann M, Schwartz AR, Zöller M, Heider KH, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53: 1262
24. Salmi M, Gron VK, Sointo P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 431
25. Samuel J, Noujaim AA, Williams DJ, Brezinska GS, Haines DM, Longenecker BM (1989) A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas. Cancer Res 49: 2465
26. Schrijvers AHGJ, Quak JJ, Uyterlinde AM, Walsum M van, Meijer CJLM, Snow GB, Dongen GAMS van (1993) mAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. Cancer Res 53: 4383
27. Seiter S, Arch R, Reher S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443
28. Stauder R, Eisterer W, Thaler J, Günthert U (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 85: 2885
29. Terpe HJ, Störkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Günthert U (1996) Expression of CD44 isoforms in renal cell tumors. Am J Pathol 148: 453
30. Thomas L, Byers HR, Vink J, Stamenkovic I (1992) CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971
31. Trowbridge IS, Lesley J, Schulte R, Hyman R, Trotter J (1982) Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed in lymphoid tissues. Immunogenetics 15: 299
32. Webb DS, Shimizu Y, Van SG, Shaw S, Gerrard TL (1990) LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249: 1295
33. Wilbur DS, Hadley SW, Hylarides MD, Abrams PG, Beaumier PA, Morgan AC, Reno JM, Fritzberg AR (1989) Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J Nucl Med 30: 216
34. Woerner SM, Givehchian M, Durst M, Schneider A, Costa S, Melsheimer P, Lacroix J, Zöller M, Knebel Doeberitz M von (1995) Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Clin Cancer Res 1: 1125